Drug reaction with eosinophilia and systemic symptoms.
De Greef
Elisabeth
E
Department of Gastroenterology, Hospital for Sick Children, Toronto, Ont.
Mennie
Katie
K
Muise
Aleixo
A
D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002097:C-Reactive Protein / Q000032:analysis; D004802:Eosinophilia / Q000139:chemically induced*; D005334:Fever / Q000139:chemically induced; D006801:Humans; D008218:Lymphocytosis / Q000139:chemically induced; D008297:Male; D017444:Skin Diseases, Papulosquamous / Q000139:chemically induced*; D012460:Sulfasalazine / Q000009:adverse effects*; D000637:Transaminases / Q000097:blood
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012460:Sulfasalazine; D002097:C-Reactive Protein; D000637:Transaminases